Pfizer lawsuit dismissed

Pfizer's (PFE) long-running lawsuit pertaining to its pain-relieving drugs Celebrex and Bextra has been dismissed prior to its scheduled trial in September.

The company was accused of misleading investors about the safety of the drugs, although the case was thrown out after the plaintiffs failed to procure evidence relating to the danger and damages of the painkillers.

PFE +0.3% AH

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs